1835-12-7

Basic information

• Product Name: 4-(Benzyloxy)-3-methoxyphenacyl Bromide
• Synonyms: 4-(Benzyloxy)-3-methoxyphenacyl Bromide;2-BroMo-1-[3-Methoxy-4-(phenylMethoxy)phenyl]ethanone;4'-(Benzyloxy)-2-broMo-3'-Methoxy-acetophenone
• CAS NO: 1835-12-7
• Molecular Formula: C₁₆H₁₅BrO₃
• Molecular Weight: 335.1925
• Product Categories: Aromatics;Intermediates;Aromatics, Intermediates
• Mol File: 1835-12-7.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• Storage Temp.: -20°C Freezer
• Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly)
• CAS DataBase Reference: 4-(Benzyloxy)-3-methoxyphenacyl Bromide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Benzyloxy)-3-methoxyphenacyl Bromide(1835-12-7)
• EPA Substance Registry System: 4-(Benzyloxy)-3-methoxyphenacyl Bromide(1835-12-7)

Safety Data

• Hazardous Substances Data: 1835-12-7(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Solid

Upstream product

• 1835-11-6 4-benzyloxy-3-methoxyacetophenone 
• 100-44-7 benzyl chloride 
• 498-02-2 1-(3-methoxy-4-hydroxyphenyl)ethanone 
• 100-39-0 benzyl bromide 
• 906668-05-1 2-(2,6-dimethoxyphenoxy)-1-(4-hydroxy-3-methoxyphenyl)ethan-1-one 
• 52041-27-7 1-(3'-methoxy-4'-(1-phenyl)methoxyphenyl)-2-(2'',6''-dimethoxyphenoxy)ethanal 

Downstream Products

• 857560-88-4 1-(4-benzyloxy-3-methoxy-phenyl)-2-(2-methoxy-4-propyl-phenoxy)-ethanone 
• 857597-68-3 4-(4-benzyloxy-3-methoxy-phenacyloxy)-3-methoxy-benzaldehyde 
• 22317-29-9 1-(4-(benzyloxy)-3-methoxyphenyl)-2-(2-methoxyphenoxy)ethan-1-one 
• 144877-82-7 α-(4-hydroxymethyl-2-methoxyphenoxy)-4-benzyloxy-3-methoxyacetophenone 
• 73053-69-7 (+/-)-trans-1-(4-benzyloxy-3-methoxyphenacyl)-5-ethyl-2-oxo-4-piperidineacetic acid ethyl ester 
• 82260-54-6 (3R,4S)-(+)-1-(4-benzyloxy-3-methoxyphenacyl)-3-ethyl-4-piperidineacetic acid ethyl ester 
• 115075-64-4 (4R,5R)-1-(4-benzyloxy-3-methoxyphenacyl)-5-ethyl-2-oxo-4-piperidineacetic acid ethyl ester 
• 165054-55-7 1-(4-Benzyloxy-3-methoxyphenyl)-2-(5,5'-dipropyl-3,3'-dimethoxy-2'-hydroxy-1,1'-biphenyl-2-yloxy)ethanone 
• 52041-27-7 1-(3'-methoxy-4'-(1-phenyl)methoxyphenyl)-2-(2'',6''-dimethoxyphenoxy)ethanal 
• 26513-91-7 ω-<2-Methoxy-4-methyl-phenoxy>-4-acetoguajcon-benzylaether 
• 1879-23-8 1-<4-Benzyloxy-3-methoxy-phenyl>-2-acetoxy-aethanon 
• 97152-08-4 ω-Dibenzylamino-3-methoxy-4-benzyloxy-acetophenon 
• 51908-39-5 1,4-Bis-(4-benzyloxy-3-methoxy-phenyl)-2-methanesulfonyl-butane-1,4-dione 
• 51908-36-2 4-(4-Benzyloxy-3-methoxy-phenyl)-2-methanesulfonyl-1-phenyl-butane-1,4-dione 

Relevant articles and documents

Thio-assisted reductive electrolytic cleavage of lignin β-O-4 models and authentic lignin

Avoiding the use of expensive catalysts and harsh conditions such as elevated temperatures and high pressures is a critical goal in lignin depolymerization and valorization. In this study, we present a thio-assisted electrocatalytic reductive approach using inexpensive reticulated vitreous carbon (RVC) as the working cathode to cleave the β-O-4-type linkages in keto aryl ethers. In the presence of a pre-electrolyzed disulfide (2,2′-dithiodiethanol) and a radical inhibitor (BHT) at room temperature at a current density of 2.5 mA cm-2, cathodic reduction of nonphenolic β-O-4 dimers afforded over 90% of the corresponding monomeric C-O cleavage products in only 1.5 h. Extended to DDQ-oxidized poplar lignin, this combination of electric current and disulfide, applied over 6 h, released 36 wt% of ethyl acetate soluble fragments and 26 wt% of aqueous soluble fragments, leaving only 38 wt% of insoluble residue. These findings represent a significant improvement over the current alone values (24 wt% ethyl acetate soluble; 22 wt% aqueous soluble; 54 wt% insoluble residue) and represent an important next step in our efforts to develop a mild electrochemical method for reductive lignin deconstruction.

Synthesis and evaluations of novel apocynin derivatives as anti-glioma agents

Apocynin (4-hydroxy-3-methoxyacetophenone) is a natural polyphenolic compound with multiple biological activities. In the present study, a series of apocynin derivatives were designed and synthesized. The in silico ADMET prediction, blood-brain barrier (B

A medicine for treating diseases of the nervous system of the new compound (by machine translation)

The invention belongs to the technical field of medicine, the compounds of the formula I structure and its pharmaceutically acceptable salt, Wherein R1, R2 is hydrogen, halogen; R3 is hydrogen, alkyl, benzyl, phenethyl. The invention also relates to the